1 report

  • 6. DPP4 INHIBITORS / CD26 ANTIGEN ANTAGONISTS
  • 4.7. GLP-1 AGONISTS, DPP4 INHIBITORS AND SGLT2 INHIBITORS: KEY

DPP## INHIBITORS BLOCK THE ACTIVITY OF GLP-## AND GIP.

  • Antidiabetics
  • Diabetes
  • Gliptins
  • Pharmaceutical
  • Pfizer Inc.